MOTS-c (Mitochondrial Peptide)

MOTS-c Nuclear Translocation Under Metabolic Stress

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

Kim, Son and Benayoun reported in Cell Metabolism in September 2018 that MOTS-c translocates from the mitochondrion to the nucleus in response to metabolic stress, where it regulates nuclear gene expression including antioxidant response element-containing genes. This is a peptide encoded in mitochondrial DNA acting on the nuclear genome.

Key facts

Publication
Cell Metabolism, 4 September 2018
PMID
29983246
Authors
Kim KH, Son JM, Benayoun BA et al.
Trigger
Metabolic stress (e.g. glucose restriction, oxidative stress)
Destination
Nucleus
Target genes
Antioxidant response element (ARE)-containing
Concept
Mitochondrial retrograde signalling

What retrograde signalling means

The nucleus controls the mitochondrion. Most mitochondrial proteins are nuclear-encoded and imported. Signalling in the other direction, from mitochondrion to nucleus, is called retrograde signalling, and it was historically understood to work through indirect intermediates such as calcium, reactive oxygen species or metabolite levels. A peptide encoded in mitochondrial DNA physically entering the nucleus and acting on transcription is a much more direct channel.

What the study reported

Under metabolic stress, MOTS-c was observed to move into the nucleus rather than remaining associated with the mitochondrion. There it participated in regulating expression of nuclear genes, with the antioxidant response element-containing set specifically identified. The behaviour was conditional on stress rather than constitutive, which is what makes it look like signalling rather than distribution.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

Why the ARE genes are the notable target

Antioxidant response elements are the promoter sequences through which the cell coordinates its response to oxidative stress. Mitochondria are the principal endogenous source of reactive oxygen species. A peptide originating in the organelle that generates the stress, acting on the nuclear programme that responds to it, is a coherent feedback architecture rather than an isolated observation.

How it fits with the AMPK mechanism

These are two separate reported activities and they should not be conflated. AMPK activation via folate-cycle inhibition is a cytosolic, metabolite-mediated effect. Nuclear translocation is a distinct behaviour under a distinct trigger. Whether they are mechanistically connected, and how, is not settled by the published work.

Reading this carefully

This is cell-biological work, and it describes what the peptide does inside cells under defined stress conditions. It says nothing about outcomes in an organism, and nothing about what administering the peptide would do. The finding is interesting because of what it reveals about mitochondrial-nuclear communication, which is a different kind of claim entirely.

Frequently asked questions

Does MOTS-c act as a transcription factor?

It regulates nuclear gene expression, but describing it as a transcription factor overstates what was reported. Its precise role at the promoter is not fully characterised.

What triggers the move to the nucleus?

Metabolic stress. The behaviour is conditional rather than constitutive, which is part of why it reads as a signalling event.

Is this unique among mitochondrial peptides?

It is the clearest demonstrated case. Whether humanin or the SHLPs do anything comparable is not established.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.